Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) &dgr;-Selective Ligands

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|22|2335-2343

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.22, 2007-09, pp. : 2335-2343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPAR) and its Lipid Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2803-2821

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004

By Miyachi Hiroyuki  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1521-1530

Informa Healthcare

Access to resources Recommend Favorite

The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 2, 2013-06 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite